News for Immune Therapeutics, Inc. (IMUN)

ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today...

[222 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global CAR T-Cell Therapy Market size &...

Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech...

The settlement between Statera Biopharma, Inc. and Biostax Corp. ...

Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April...

ORLANDO, March 01, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC Pink: IMUN) ("Immune" or "IMUN"), a specialty pharmaceutical company involved...

Orlando, FL, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC PINK:IMUN) (“Immune” or “IMUN”) today announced that its Chief Executive...

Read Immune Therapeutics (OTCMKTS:IMUND) Shares Up 112.1% at ETF Daily News

ORLANDO, FL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC PINK:IMUN) ("Immune" or "IMUN"), a specialty pharmaceutical company...

Read Immune Therapeutics (OTCMKTS:IMUN) versus Catalyst Pharmaceuticals (NASDAQ:CPRX) Financial Contrast at ETF Daily News

FORT COLLINS, Colo., May 23, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating...

VANCOUVER, BC , April 21, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”)...

Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update Management to Host Conference Call Today, Monday, November 15, 2021, 5:30 p.m. ET ... | November 15, 2021

There is increased research and development for new drug discovery for the treatment of Esophageal Cancer. There are more than 80+ companies that are...